Verona Pharma plc (VRP.L) (LON:VRP – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 55 ($0.68) and traded as high as GBX 56 ($0.70). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.68), with a volume of 70,791 shares traded.
Verona Pharma plc (VRP.L) Stock Performance
The company has a current ratio of 2.99, a quick ratio of 2.47 and a debt-to-equity ratio of 6.85. The firm’s 50-day moving average is GBX 55 and its two-hundred day moving average is GBX 55. The stock has a market cap of £228.00 million and a price-to-earnings ratio of -1.68.
About Verona Pharma plc (VRP.L)
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.
Featured Articles
- Five stocks we like better than Verona Pharma plc (VRP.L)
- How to Effectively Use the MarketBeat Ratings Screener
- United Airlines Soars on Earnings Beat
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- J.B. Hunt Hits the Skids: Lower Prices to Come
- P/E Ratio Calculation: How to Assess Stocks
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.